Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug 15;7(8):102-10.
doi: 10.4251/wjgo.v7.i8.102.

Neoadjuvant or adjuvant therapy for gastric cancer

Laurent Quéro  1 , Sophie Guillerm  1 , Christophe Hennequin  1
Affiliations
Review

Neoadjuvant or adjuvant therapy for gastric cancer

Laurent Quéro et al. World J Gastrointest Oncol. .

Abstract

Currently, there is no international consensus on the best treatment regimen for patients with advanced resectable gastric carcinoma. In the United States, where a limited lymph-node dissection is frequently performed, adjuvant chemoradiotherapy after surgery is the standard treatment. In Europe, intensified perioperative chemotherapy is commonly administered. In Japan and South Korea, postoperative S-1-based adjuvant chemotherapy after surgery with D2 lymph-node dissection is the standard treatment. Several ongoing trials are currently evaluating the optimal sequence of chemotherapy, radiotherapy, and surgery, as well as the place of targeted therapeutic agents in the treatment of advanced gastric carcinoma.

Keywords: Chemotherapy; Gastric cancer; Radiotherapy; Review.

PubMed Disclaimer

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
    1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. - PubMed
    1. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700–713. - PMC - PubMed
    1. Meyerhardt JA, Fuchs CS. Adjuvant therapy in gastric cancer: can we prevent recurrences? Oncology (Williston Park) 2003;17:714–21, 728; discussion 728-9, 732-3. - PubMed
    1. Abad A, Manzano JL, Martí C. Reflections on adjuvant treatment of gastric cancer. Ther Clin Risk Manag. 2007;3:563–567. - PMC - PubMed

LinkOut - more resources